What are the recommended antibiotics and durations for treating syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment: Antibiotics and Duration

First-Line Treatment Recommendations

Benzathine penicillin G is the definitive treatment for syphilis, with dosing and duration determined by disease stage. 1, 2

Primary and Secondary Syphilis (Early Syphilis)

  • Benzathine penicillin G 2.4 million units IM as a single dose 1, 2
  • This single injection is highly effective and remains the gold standard after decades of clinical use 3, 4
  • Treatment should achieve a fourfold decline in nontreponemal titers (RPR/VDRL) within 6 months 1, 5

Early Latent Syphilis (Acquired Within Past Year)

  • Benzathine penicillin G 2.4 million units IM as a single dose 6, 7
  • Early latent is defined by documented seroconversion, fourfold titer increase, symptoms within the past year, or partner with documented early syphilis 7, 2

Late Latent Syphilis or Unknown Duration

  • Benzathine penicillin G 7.2 million units total: three doses of 2.4 million units IM given at weekly intervals 6, 1, 7
  • This extended regimen is necessary to prevent progression to tertiary complications 6

Neurosyphilis (Any Stage)

  • Aqueous crystalline penicillin G 18-24 million units IV daily (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days 1, 8
  • Some experts recommend additional therapy with benzathine penicillin G 2.4 million units IM weekly for 3 doses after completing IV therapy 8
  • CSF examination is mandatory before treatment if neurologic/ophthalmic symptoms, tertiary syphilis signs, treatment failure, HIV with late latent syphilis, or nontreponemal titer ≥1:32 are present 6, 7

Tertiary Syphilis (Cardiovascular/Gummatous)

  • Benzathine penicillin G 7.2 million units total: three doses of 2.4 million units IM at weekly intervals 6, 2

Alternative Regimens for Penicillin Allergy

For non-pregnant patients only (pregnant patients must undergo penicillin desensitization—no exceptions): 6, 2

Primary, Secondary, or Early Latent Syphilis

  • Doxycycline 100 mg orally twice daily for 14 days 6, 1, 9
  • Alternative: Tetracycline 500 mg orally four times daily for 14 days 6
  • Doxycycline is preferred over tetracycline due to better compliance 6

Late Latent Syphilis or Unknown Duration

  • Doxycycline 100 mg orally twice daily for 28 days 6, 1, 9
  • Alternative: Tetracycline 500 mg orally four times daily for 28 days 6

Critical Caveat for Alternatives

  • CSF examination must exclude neurosyphilis before using non-penicillin regimens 7
  • Close follow-up is essential as clinical experience with alternatives is more limited than with penicillin 6

Special Population Considerations

Pregnancy

  • Penicillin is the ONLY acceptable treatment—it is the only therapy proven to prevent congenital syphilis and treat fetal infection 2, 10
  • Pregnant patients with penicillin allergy must undergo desensitization followed by stage-appropriate penicillin treatment 6, 1, 2
  • Some experts recommend a second dose of benzathine penicillin 2.4 million units IM one week after initial dose for primary, secondary, or early latent syphilis in pregnancy 2
  • Screen all pregnant patients at first prenatal visit, third trimester, and delivery 1, 10
  • Warn patients about Jarisch-Herxheimer reaction risk during second half of pregnancy, which may precipitate premature labor or fetal distress 2

HIV-Infected Patients

  • Use the same penicillin regimens as non-HIV-infected patients 2, 5
  • More frequent follow-up is mandatory (every 3 months instead of 6 months) to detect treatment failure 6, 5
  • CSF examination should be performed for all HIV-infected patients with late latent syphilis or unknown duration 6, 7
  • HIV-infected patients with RPR titers ≥1:32 and/or CD4 counts <350 cells/mm³ may be at increased risk for asymptomatic neurosyphilis 5

Pediatric Dosing (Acquired Syphilis After Newborn Period)

  • CSF examination required before treatment to exclude neurosyphilis 6, 7
  • Early latent: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) as single dose 6, 7
  • Late latent or unknown duration: Benzathine penicillin G 50,000 units/kg IM (up to adult dose of 2.4 million units) given as three doses at weekly intervals (total 150,000 units/kg up to 7.2 million units) 6, 7

Follow-Up Protocol

Early Syphilis (Primary, Secondary, Early Latent)

  • Repeat quantitative nontreponemal tests (RPR or VDRL) at 6 and 12 months 1, 5
  • Expect fourfold decline in titer within 6 months 1, 2
  • HIV-infected patients: follow-up at 3,6,9,12, and 24 months 6

Late Latent Syphilis

  • Repeat quantitative nontreponemal tests at 6,12, and 24 months 6
  • Expect fourfold decline within 12-24 months 2, 5

Indicators for Re-Treatment

Re-evaluate and consider re-treatment if: 6

  • Titers increase fourfold
  • Initially high titer (≥1:32) fails to decline at least fourfold within appropriate timeframe
  • Signs or symptoms of syphilis develop
  • When re-treating, use three weekly injections of benzathine penicillin G 2.4 million units IM unless CSF indicates neurosyphilis 6

Partner Management

Presumptive treatment is recommended for exposed partners even if seronegative: 2, 10

  • Partners exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should receive benzathine penicillin G 2.4 million units IM 1
  • Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 2

Important Clinical Pitfalls to Avoid

What NOT to Use

  • Azithromycin should NOT be used due to widespread macrolide resistance and documented treatment failures in the United States 2, 5
  • Oral penicillin preparations are ineffective for syphilis treatment 2
  • Erythromycin does not reliably cure fetal infection and is inadequate in pregnancy 2
  • Single-dose ceftriaxone is not effective; if used, must be 1 gram daily for 10 days 6, 2

Jarisch-Herxheimer Reaction

  • Inform all patients about this acute febrile reaction that may occur within 24 hours after treatment, especially in early syphilis 1, 2
  • Symptoms include fever, headache, myalgia, and other flu-like symptoms 1
  • In pregnant patients during second half of pregnancy, may precipitate premature labor or fetal distress—advise immediate medical attention for contractions or changes in fetal movements 2

Testing Considerations

  • All patients with syphilis should be tested for HIV at diagnosis 1, 2
  • Do not switch between different nontreponemal tests (RPR vs VDRL) when monitoring response, as results cannot be directly compared 2
  • Treponemal antibody titers correlate poorly with disease activity and should not be used to assess treatment response 2

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of secondary syphilis.

Journal of the American Venereal Disease Association, 1976

Research

Management of adult syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Latent Stage Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.